vevye
Pharmaranks rates Vevye 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Vevye (Cyclosporine) is a calcineurin inhibitor immunosuppressant used to treat Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus, Myasthenia Gravis.
Cyclosporine · by Harrow Eye
Available as a generic: Gengraf
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Cyclosporine
- Drug class
- Calcineurin Inhibitor Immunosuppressant
- Form
- Drops
- Strength
- Cyclosporine 0.1%
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Harrow Eye
- Half-life
- about 8.4 hours (range 5 to 18 hours) (how long it stays in your system)
- What the pharmacy pays
- ~$52.85 for 30 — not your price
- FDA application
- NDA217469
What is Vevye?
From the FDA label:VEVYE (cyclosporine ophthalmic solution) 0.1% contains the immunomodulatory agent cyclosporine. Cyclosporine's chemical name is Cyclo[[€-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl] and it has the following structure: Structural Formula Formula: C 62 H 111 N 11 O 12 , Molecular weight: 1202.6 Cyclosporine is a white powder that is solubilized in perfluorobutylpentane, a semi-fluorinated alkane vehicle. VEVYE is supplied as a 2 mL sterile, clear, colorless, non-aqueous ophthalmic solution for topical ophthalmic use. VEVYE ® contains: Active: cyclosporine 0.1% Inactives: perfluorobutylpentane, ethanol (anhydrous). The solution does not contain water or anti-microbial preservatives. As a water free product, there is no associated pH and no osmolarity. Structural Formula
How to use
Instill one drop of VEVYE twice a day in each eye approximately 12 hours apart. ( 2 ) 2.1 Recommended Dosage Instill one drop of VEVYE twice a day in each eye approximately 12 hours apart. 2.2 Administration Instructions Wash hands before using. Gently pull the lower eyelid downward. Tip the bottle upside down over the eye to allow one drop to dispense on its own into the eye. If a drop does not dispense after a few seconds, gently apply slight pressure to the sides of the bottle while holding over the eye. Note: You may not feel the drop falling into your eye. If VEVYE is used with other eye drops, a 15-minute interval between products should occur.
Side effects
The most common adverse reaction following the use of VEVYE were instillation site reactions (8%). ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Harrow at 1-833-4HARROW(427769) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In clinical trials with 738 subjects receiving at least 1 dose of VEVYE, the most common adverse reactions were instillation site reactions (8%) and temporary decreases in visual acuity (3%).
Warnings
Important safety information
Care should be taken to not touch the eye or other surfaces with the bottle tip to avoid potential for eye injury and/or contamination. ( 5.1 ) 5.1 Potential for Eye Injury and Contamination To avoid the potential for eye injury and/or contamination, patients should not touch the bottle tip to the eye or other surfaces. 5.2 Use with Contact Lenses VEVYE should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following administration of VEVYE ophthalmic solution.
Who should not take Vevye
None. None. ( 4 )
Foods & drinks to be careful with
Well-established interactions for this medicine’s drug class, summarized from public health authorities. General information, not medical advice — always confirm with your pharmacist or the label.
Grapefruit & grapefruit juice
Watch out for: grapefruit and grapefruit juice (and, for some drugs, Seville oranges).
Grapefruit blocks a gut enzyme (CYP3A4) that normally breaks this medicine down, so more of it can enter your blood — raising the risk of side effects.
What to do: Avoid grapefruit and grapefruit juice with this medicine unless your pharmacist or the label says it's fine — check, because not every drug in a class is affected the same way.
Source: Grapefruit Juice and Some Drugs Don't Mix — U.S. FDA
How long does Cyclosporine stay in your body?
The elimination half-life of cyclosporine is about 8.4 hours (range 5 to 18 hours) — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This figure is for the modified formulation (Neoral). Cyclosporine's disposition from blood is biphasic; the ~8.4-hour value is the terminal (elimination) half-life, not the faster distribution phase. The older non-modified formulation (Sandimmune) has a longer terminal half-life of about 19 hours (range 10 to 27 hours), so the number depends on which product a person takes. Half-life is not the same as the drug-test/detection window — elimination is almost entirely biliary (only ~6% appears in urine), and cyclosporine is extensively metabolized to numerous metabolites, so measurable drug can persist longer than the parent half-life implies. Not a prodrug; no single active metabolite that clinically outlasts the parent.
This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: NEORAL (cyclosporine) capsule/oral solution — FDA label, DailyMed.
Drug class
How this class works, per Calcineurin Inhibitors - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
- rheumatoid arthritis
- focal segmental glomerulosclerosis
- systemic lupus erythematosus
- myasthenia gravis
- psoriasis
See how Vevye ranks — best-rated calcineurin inhibitor immunosuppressant for:
Dosage forms
Drops
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Vevye treat?
- Vevye (Cyclosporine) may be used to treat rheumatoid arthritis, focal segmental glomerulosclerosis, systemic lupus erythematosus, myasthenia gravis, psoriasis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Vevye work?
- Vevye is a calcineurin inhibitor immunosuppressant. Calcineurin inhibitors block an enzyme called calcineurin inside immune T-cells, which stops the cells from making interleukin-2 and other signaling chemicals. This keeps T-cells from activating and multiplying, dialing down the immune attack that drives organ rejection or autoimmune disease.
- How is Vevye rated?
- pharmaranks gives Vevye a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Vevye cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $52.85 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Vevye?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vevye. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Vevye?
- Vevye is marketed by Harrow Eye. You can see Harrow Eye's full profile, rating, and other products on pharmaranks.
- Is Vevye a brand-name or generic drug?
- Vevye is a brand-name product with the active ingredient Cyclosporine. Lower-cost generic equivalents containing Cyclosporine are available — ask your pharmacist.
- Is Vevye available over the counter?
- No. Vevye is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Vevye come in?
- Vevye is currently marketed as drops, per the FDA's National Drug Code Directory.
- What class of drug is Vevye?
- Vevye is classified as calcineurin inhibitor immunosuppressant, per the FDA's Established Pharmacologic Class.
- Is Vevye FDA-registered?
- Vevye is on record with the U.S. FDA under application number NDA217469. You can verify this on its official FDA label.
- Has Vevye been recalled by the FDA?
- Vevye has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Vevye safe?
- There's no single safe-or-not verdict. pharmaranks gives Vevye a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
- What are the side effects of Vevye?
- Vevye's side effects are taken directly from its FDA label. From the label: The most common adverse reaction following the use of VEVYE were instillation site reactions (8%). ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Harrow at 1-833-4HARROW(427769) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .… Both common and serious reactions are documented in full on this page. This is general reference from the FDA, not medical advice — always consult a professional.
Clinical content sourced from the FDA label via openFDA (U.S. FDA). View the FDA label on DailyMed → Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
gengraf
Cyclosporine
prograf
Tacrolimus
restasis
Cyclosporine
restasis multidose
Cyclosporine
astagraf xl
Tacrolimus
neoral
Cyclosporine
Compare Vevye head-to-head
More calcineurin inhibitor immunosuppressant drugs
Guides for this medication
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
vevye
70/100